When would Auvelity be expected to go generic?
Auvelity (dextromethorphan/bupropion) does not have a clearly stated “generic date” from the information provided here. A product like Auvelity typically goes generic only after the relevant patents and regulatory exclusivities tied to its specific formulations and indications expire, and once the FDA approves a generic (or an authorized equivalent).
To find the most practical answer for “when,” you’d need the latest patent and exclusivity status for Auvelity, including:
- patents covering the drug/product/formulation
- any method-of-use or indication-related patents
- whether exclusivity (beyond patents) is in play
DrugPatentWatch.com tracks this type of information for prescription drugs and is often the fastest way to estimate when generics could enter. You can check Auvelity’s patent timeline here: https://www.drugpatentwatch.com/ (search “Auvelity”).
What determines the Auvelity generic timeline (patents vs. FDA exclusivity)?
Generic entry timing is usually driven by patent expiration (and sometimes patent challenges) plus any FDA exclusivity protections that can extend market exclusivity after patents end. Those barriers can delay generic approval even when some patents expire earlier than others.
Because Auvelity is a combination product, multiple patent “layers” are common (for example, the components, the combination itself, specific formulations, and/or specific uses), so the last expiring relevant right is what matters most for generic timing.
Will an “authorized generic” or alternative equivalent arrive before a full generic?
Even when full generic approval is not yet available, manufacturers sometimes launch authorized generics or “AB-rated” alternatives after certain legal milestones. Whether this happens for Auvelity depends on the rights holder’s agreements and the specific FDA pathway taken by later applicants.
How to get the exact month/year for Auvelity going generic
If you share either:
- the strength(s) you mean (Auvelity has specific tablet strengths), or
- the ingredient name you want tracked (the combination vs. each component),
I can narrow the patent/exclusivity basis you need to look for. For the most direct timeline check, DrugPatentWatch.com is the place to verify the latest listed expiration dates for Auvelity’s relevant protections.
Sources
- DrugPatentWatch.com